Botulinum toxin: Pharmacology and injectable administration for the treatment of primary hyperhidrosis.

Journal of the American Academy of Dermatology 2020 Vol.82(4) p. 969-979

Nawrocki S, Cha J

관련 도메인

Abstract

Hyperhidrosis is a dermatological condition defined by excessive sweating beyond thermoregulatory needs with significant effects on patients' quality of life. Hyperhidrosis is categorized as primary or secondary: primary hyperhidrosis is mostly focal and idiopathic, whereas secondary hyperhidrosis is commonly generalized and caused by an underlying medical condition or use of medications. Various surgical and nonsurgical therapies exist for primary hyperhidrosis. Although botulinum toxin is one of the deadliest toxins known, when used in small doses, it is one of the most effective therapies for primary hyperhidrosis. Botulinum toxin injections are widely used as a second-line primary hyperhidrosis treatment option once topical treatment strategies have failed. This article provides an overview of the commercially available botulinum toxin formulations and their applications in the treatment of primary hyperhidrosis.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 4

MeSH Terms

Acetylcholine; Acetylcholine Release Inhibitors; Axilla; Botulinum Toxins, Type A; Dose-Response Relationship, Drug; Exocytosis; Humans; Hyperhidrosis; Injection Site Reaction; Injections, Intradermal; Neuromuscular Junction; Presynaptic Terminals; Quality of Life; Sweat Glands; Treatment Outcome; United States

📑 인용 관계

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문